Effects of Therapeutic Exercise in Patients With Fibromyalgia
- Conditions
- Chronic PainTherapeutic Exercise
- Interventions
- Other: Therapeutic Exercise
- Registration Number
- NCT04817605
- Lead Sponsor
- Universidad de Zaragoza
- Brief Summary
Fibromyalgia syndrome is characterized by chronic generalized musculoskeletal pain associated with fatigue, sleep disturbances and some biochemical markers. The European League Againts Rheumatism (EULAR) described an algorithm how to treat step by step these patients.
The objective of this trial is to evaluate if therapeutic exercise is effective on fatigue, pain threshold, quality of life, quality of sleep, pain coping and biochemical and genetic markers.
For this purpose, the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of fibromyalgia according to the American College of Rheumatology (ACR).
Patients included one group receiving exercise therapy consisting of 3 treatment sessions a week over 10 weeks.
The variables are measured at the beginning and end of treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 30
- Diagnosed medically with Fibromyalgia
- Diagnosed according to the American College of Rheumatology criteria
- Agreement to attend to treatment sessions
- Any kind of contraindications for physical activity
- Other kind of diseases that could limit the intervention
- Previous surgery last year
- Medication modifications in the last 3 months
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Exercise Therapy Therapeutic Exercise -
- Primary Outcome Measures
Name Time Method Quality of Sleep through study completion, an average 10 weeks The investigators measure the quality of sleep with Pittsburg Sleeping Questionnaire Index (PSQI) at baseline
Pain intensity through study completion, an average 10 weeks VAS
- Secondary Outcome Measures
Name Time Method Analysis of tryptophan metabolites through study completion, an average 10 weeks The investigators measure the tryptophan metabolites with blood test analysis at baseline
Pressure pain threshold through study completion, an average 10 weeks The investigators measure the pressure pain threshold of the 18 points described initially by the American College of rheumatology with a digital algometer at the end of treatment
Central sensitization through study completion, an average 10 weeks The investigators measure the central sensitization with Chronic Pain Self-Efficacy Scale (CPSS)
Trial Locations
- Locations (1)
Sandra Jiménez Jiménez-del-Barrio
🇪🇸Soria, Spain